CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor

by Ysios Capital

CorWave raises 35 million euros to fund the next stages of its development, with the ambition to become a world-class medtech company serving heart failure patients. The capital increase is subscribed...

Read more

Covid-19 drives innovation and makes healthcare investment spike

by Biocat

Covid-19 pandemic has boosted cutting-edge research and innovation, reaching a record investment for companies in the BioRegion

Read more

Flomics Investment opportunity

by Flomics Biotech SL

Flomics Biotech, a startup from the Barcelona Biomedical Research Park (PRBB) operating in the genomics and liquid biopsy fields is excited to announce the launch of its seed investment round of 500.0...

Read more

Azbil Receives 'A+' Issuer Rating from Rating and Investment Information

by Telstar

Azbil Corporation has been issued with an A+ rating from ‘Rating and Investment Information, Inc.’ The reason for the rating upgrade lies in that stable earnings sources, such as maintenance servi...

Read more

ITEMAS is in favour of the creation of a fund or investment instrument for early stage projects

by GENESIS Biomed

Which are the needs of innovation projects born in medical centres? Which are the limitations to bring them to market? Innovation experts gave their views at the 1st ITE​MAS webinar about “Investm...

Read more

Chemotargets opens an investment round of 15M euros to enter a new phase of growth

by GENESIS Biomed

Chemot​argets, a global leader in predictive analytics solutions for the pharma and biotech sector, begins a phase of transformation to become a biotechnology company that will develop new medicines...

Read more

Chemotargets opens an investment round to enter a new phase of growth

by GENESIS Biomed

GENESIS Biomed and CREA Inversión will advise in the funding, which will allow the company to expand its activity in the discovery of new drugs

Read more

Rounds of funding, grants, pipeline advances, appointments and discoveries in leukemia

by Biocat

Rounds at Ability, Elma and Vytrus and “la Caixa” grants, among the top headlines in September

Read more

Catalan biomedical companies attracted €106 million in investment in 2018 for new drugs and technology

by CataloniaBio

Venture capital funds continue to lead investment, but there is growing interest in the sector from business angels. 60% of Catalan pharmaceutical groups invest in start-ups to fuel open innovation.

Read more

Biomedical industry in Catalonia raises €102 million in investment in 2017

by Parc Científic de Barcelona

Catalan biomedical companies attracted €102 million in investment in 2017, with €3.4 million per operation, on average. This will allow them to push forward in the development of drugs and innovat...

Read more

Catalan biomedical companies attracted €153.1 million in investment in 2016

by Parc Científic de Barcelona

Catalan biomedical companies were able to attract €153.1 million in investment in 2016, a record figure for the sector. This is the main takeaway from the first Study on investment in the Biomedical...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Theriva™ Biologics to Present Preclini...

by Theriva™ Biologics

Theriva™ Biologics has announced the presentation of preclinical da...

Photos Stream